JC

Jeremy Caldwell

Investor at Red Tree Investor

San Diego, California

Overview 

Work Experience 

  • Board Member

    2023 - Current

Sardona Therapeutics is a Scaling New Peaks in Cancer Therapy.

  • Partner, Red Tree Venture Capital

    2023

  • Board of Directors

    2021 - 2023

Belharra Therapeutics disrupts the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform.

Raised $50,000,000.00 from Versant Ventures.

  • Venture Partner

    2018 - 2023

Versant Ventures caters to the healthcare sector with early and later stage venture, private equity, and debt financing investments.

  • President and Chief Executive Officer

    2018 - 2023

  • Board of Directors

    2020 - 2021

Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.

Raised $226,600,000.00 from Blue Owl, Redmile Group, Alexandria Venture Investments, Invus, Marshall Wace, Franklin Templeton, Venrock Healthcare Capital Partners, RTW Investments, Eli Lilly and Cowen Healthcare Investments.

  • Board of Directors

    2019 - 2020

  • President and Chief Executive Officer

    2018 - 2018

  • Executive Vice President and Chief Scientific Officer

    2014 - 2018

Ardelyx develops novel oral therapeutics to treat mineral metabolism and metabolic disorders.

Raised $557,675,321.00 from Kyowa Kirin, HealthCare Royalty Partners and SLR Capital Partners.

  • Entrepreneur in Residence

    2014 - 2014

Articles About Jeremy

Relevant Websites